The Structure-Based Drug Discovery Symposium aims to provide an overview of the current situation, challenges and future perspectives within structure-based drug discovery. The program gathers keynote talks by eminent speakers, from both academia and the pharmaceutical industry, covering all the areas of structure - based drug design with special focus on FBLD. We hope that the symposium will attract interest of the scientific community within various relevant areas including structural biology, pharmacology, computational and medicinal chemistry. The symposium is open for registration to all the scientists, both PhD students, post-docs and senior researchers. The symposium takes place 18 September - register here.
The Fragment-Based Lead Discovery Course will begin with two days of lectures at LINXS, followed by two days of practical work at MAX IV Laboratory and LINXS. The lectures 19-20/9 are open to everyone who wants to learn more about practical aspects of FBLD, whereas the practical is intended for early career scientists. Register here.
For more information on fragment-based drug discovery, take a look at the new Fragment-Screen project.
